SectorBiological Technology
Established Date29/08/2016
Listing Date08/08/2019
ExchangeNASDAQ Stock Exchange
Full-time Employees123
Fiscal Year Ends31/12
Security TypeCommon stock
Office address170 Park Ave, Florham Park, NJ 07932
Business
IntroductionCelularity Inc. was incorporated under the laws of the State of Delaware on August 29, 2016. Cellarity is a clinical-stage biotechnology company that is leading the next development direction of cell medicine by developing off-the-shelf placenta-derived allogeneic T cells, utilizing chimeric antigen receptor cells, natural killer cells (" NK ") cells and mesenchymal adhesion stromal cells (" ASCs ") for cancer, infectious and degenerative diseases. Cellarity believes that by leveraging the unique biology and ready availability of the placenta, it will be able to develop therapeutic solutions to meet the significant global demand for effective, accessible and affordable treatments.
